| Schedule of significant expense categories |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
Operating Expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
PMN310 development program costs |
|
$ |
8,761,024 |
|
$ |
1,914,804 |
|
$ |
21,537,975 |
|
$ |
4,537,978 |
|
Other non-employee research and development costs |
|
|
214,128 |
|
|
205,722 |
|
|
712,712 |
|
|
624,694 |
|
Employee costs |
|
|
1,520,464 |
|
|
1,020,095 |
|
|
4,016,789 |
|
|
2,137,126 |
|
Other general and administrative costs |
|
|
1,254,816 |
|
|
1,294,056 |
|
|
3,127,713 |
|
|
3,525,235 |
|
Net Operating Loss: |
|
|
11,750,432 |
|
|
4,434,677 |
|
$ |
29,395,189 |
|
$ |
10,825,033 |
|
Other segment items(a) |
|
|
(170,306) |
|
|
(13,710,502) |
|
|
(350,130) |
|
|
(13,842,113) |
|
Net Loss (Income): |
|
|
11,580,126 |
|
|
(9,275,825) |
|
$ |
29,045,059 |
|
$ |
(3,017,080) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Profit or Loss |
|
$ |
|
|
$ |
|
|
|
|
|
|
|
|
Adjustments and reconciling items |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Consolidated Net Loss (Income): |
|
|
11,580,126 |
|
|
(9,275,825) |
|
$ |
29,045,059 |
|
$ |
(3,017,080) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)Other segment items included in segment loss include changes in warrant liability, interest income, and interest expense |
|